期刊
JHEP REPORTS
卷 3, 期 2, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.jhepr.2020.100220
关键词
Microbiome; Mycobiome; Virome; Alcohol; Cirrhosis; Hepatitis; Bile acids
资金
- NIH [R01 AA020703, R01 AA24726, U01 AA026939]
- Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [BX004594]
- [P30 DK120515]
- [P50 AA011999]
Alcohol-related liver disease encompasses a spectrum of conditions, not all heavy drinkers develop severe forms, and the intestinal microbiome may play a role. This review explores the microbiome's role in different stages of alcohol-related liver disease, discussing its effects on disease pathogenesis.
Alcohol-related liver disease characterises a broad spectrum of hepatic diseases that result from heavy alcohol use, and include alcohol-related steatosis, steatohepatitis, fibrosis, cirrhosis, and alcoholic hepatitis. Amongst heavy drinkers, progression to more severe forms of alcohol-related liver disease is not universal, with only 20% developing cirrhosis and up to one-third developing alcoholic hepatitis. Non-alcohol-related triggers for severe disease are not well understood, but the intestinal microbiome is thought to be a contributing factor. This review examines the role of the microbiome in mild alcohol-related liver disease, cirrhosis, and alcoholic hepatitis. While most of the literature discusses bacterial dysbiosis, we also discuss the available evidence on fungal (mycobiome) and virome alterations in patients with alcohol-related liver disease. Additionally, we explore the mechanisms by which the microbiome contributes to the pathogenesis of alcohol-related liver disease, including effects on intestinal permeability, bile acid dysregulation, and production of hepatotoxic virulence factors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据